Cite
Discovery of 5-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)-1H-indole-2-carboxamide derivatives as novel anti-cancer agents targeting Nur77.
MLA
Qin, Jingbo, et al. “Discovery of 5-((4-(Pyridin-3-Yl)Pyrimidin-2-Yl)Amino)-1H-Indole-2-Carboxamide Derivatives as Novel Anti-Cancer Agents Targeting Nur77.” European Journal of Medicinal Chemistry, vol. 244, Dec. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ejmech.2022.114849.
APA
Qin, J., Chen, X., Liu, W., Chen, J., Liu, W., Xia, Y., Li, Z., Li, M., Wang, S., Yuan, Q., Qiu, Y., Wu, Z., & Fang, M. (2022). Discovery of 5-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)-1H-indole-2-carboxamide derivatives as novel anti-cancer agents targeting Nur77. European Journal of Medicinal Chemistry, 244, N.PAG. https://doi.org/10.1016/j.ejmech.2022.114849
Chicago
Qin, Jingbo, Xiaohui Chen, Weihao Liu, Jun Chen, Weirong Liu, Yongzhen Xia, Zhehui Li, et al. 2022. “Discovery of 5-((4-(Pyridin-3-Yl)Pyrimidin-2-Yl)Amino)-1H-Indole-2-Carboxamide Derivatives as Novel Anti-Cancer Agents Targeting Nur77.” European Journal of Medicinal Chemistry 244 (December): N.PAG. doi:10.1016/j.ejmech.2022.114849.